Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06233942
What this trial is testing

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 308
Testing effectiveness (Phase 2)Study completedNCT01484873
What this trial is testing

Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor

Who this might be right for
ObesityOverweightCraniopharyngioma
Vanderbilt University Medical Center 10
Testing effectiveness (Phase 2)WithdrawnNCT06233903
What this trial is testing

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)
Not applicableLooking for participantsNCT04340024
What this trial is testing

Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients

Who this might be right for
Nasopharyngeal CancerProstate CancerOther Cancer
National Cancer Centre, Singapore 5,000
Not applicableActive Not RecruitingNCT03728842
What this trial is testing

Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Melanoma; Renal Cell Carcinoma
Indiana University 19
Early research (Phase 1)Looking for participantsNCT05907980
What this trial is testing

A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Chugai Pharmaceutical 209
Testing effectiveness (Phase 2)Ended earlyNCT04824794
What this trial is testing

GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed or Refractory Multiple Myeloma (RRMM)Diffuse Large B Cell Lymphoma (DLBCL)Acute Myeloid Leukemia (AML)
Genmab 130
Not applicableStudy completedNCT04066361
What this trial is testing

OPTimizing Treatment Focused Genetic Testing IN Cancer

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+1 more
Dana-Farber Cancer Institute 301
Not applicableStudy completedNCT00376922
What this trial is testing

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Wake Forest University Health Sciences 65
Early research (Phase 1)Study completedNCT02588105
What this trial is testing

Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 84
Early research (Phase 1)Study completedNCT04908176
What this trial is testing

A Drug-drug Interaction Study of Avapritinib and Midazolam

Who this might be right for
Gastrointestinal Stromal TumorsGISTNon-resectable Advanced Solid Tumors+1 more
Blueprint Medicines Corporation 10
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Testing effectiveness (Phase 2)Study completedNCT00284817
What this trial is testing

Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer

Who this might be right for
Cancer
MedImmune LLC 17
Not applicableLooking for participantsNCT06781749
What this trial is testing

New Approach to Objectively Measure Social Engagement in Older Adults With Hearing Loss

Who this might be right for
Hearing Loss, Bilateral (Causes Other Than Tumors)
University of Southern California 100
Testing effectiveness (Phase 2)Ended earlyNCT06069778
What this trial is testing

Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
BioNTech SE 1
Not applicableStudy completedNCT04295174
What this trial is testing

KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and Other Biomarkers

Who this might be right for
Carcinoma, Renal Cell
Odense University Hospital 70
Not applicableStudy completedNCT01047878
What this trial is testing

Genomic Analysis of Pediatric Bone Tumors

Who this might be right for
Bone Cancer
Stanford University 163
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT05332574
What this trial is testing

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Who this might be right for
NSCLCOther Solid Tumors
Genor Biopharma Co., Ltd. 120
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Next Page